Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| AVTX | Sullivan Christopher Ryan | Chief Financial Officer | 09/16/2026 | Verkauf | 16.33 | 12,394 | 202,437 | Form 4 |
| AVTX | Sullivan Christopher Ryan | Chief Financial Officer | 09/16/2026 | Optionsausübung | 9.88 | 12,394 | 122,453 | Form 4 |
| AVTX | Sullivan Christopher Ryan | Chief Financial Officer | 09/10/2026 | Verkauf | 17.62 | 10,185 | 179,457 | Form 4 |
| AVTX | Sullivan Christopher Ryan | Chief Financial Officer | 09/10/2026 | Optionsausübung | 8.04 | 10,185 | 81,887 | Form 4 |
| AVTX | Doyle Mittie | Chief Medical Officer | 08/28/2026 | Verkauf | 20.00 | 679 | 13,580 | Form 4 |
| AVTX | Doyle Mittie | Chief Medical Officer | 08/28/2026 | Optionsausübung | 8.04 | 679 | 5,459 | Form 4 |
| AVTX | Sullivan Christopher Ryan | Chief Financial Officer | 08/18/2026 | Verkauf | 20.05 | 31,031 | 622,324 | Form 4 |
| AVTX | Sullivan Christopher Ryan | Chief Financial Officer | 08/18/2026 | Optionsausübung | 9.88 | 31,031 | 306,586 | Form 4 |
| AVTX | Doyle Mittie | Chief Medical Officer | 08/17/2026 | Verkauf | 20.00 | 1,000 | 20,000 | Form 4 |
| AVTX | Doyle Mittie | Chief Medical Officer | 08/17/2026 | Optionsausübung | 12.65 | 1,000 | 12,650 | Form 4 |
| AVTX | Sullivan Christopher Ryan | Chief Financial Officer | 08/17/2026 | Verkauf | 19.94 | 3,749 | 74,762 | Form 4 |
| AVTX | Sullivan Christopher Ryan | Chief Financial Officer | 08/17/2026 | Verkauf | 19.85 | 37,945 | 753,333 | Form 4 |
| AVTX | Sullivan Christopher Ryan | Chief Financial Officer | 08/17/2026 | Optionsausübung | 9.88 | 2,876 | 28,415 | Form 4 |
| AVTX | Sullivan Christopher Ryan | Chief Financial Officer | 08/17/2026 | Optionsausübung | 9.88 | 37,945 | 374,897 | Form 4 |
| AVTX | Riley Jennifer | Chief Strategy Officer | 08/11/2026 | Verkauf | 19.59 | 2,655 | 52,012 | Form 4 |
| AVTX | Doyle Mittie | Chief Medical Officer | 08/10/2026 | Verkauf | 20.00 | 679 | 13,580 | Form 4 |
| AVTX | Doyle Mittie | Chief Medical Officer | 08/10/2026 | Optionsausübung | 8.04 | 679 | 5,459 | Form 4 |
| AVTX | Doyle Mittie | Chief Medical Officer | 07/27/2026 | Verkauf | 20.00 | 1,000 | 20,000 | Form 4 |
| AVTX | Doyle Mittie | Chief Medical Officer | 07/27/2026 | Optionsausübung | 12.65 | 1,000 | 12,650 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).